Bristol-Myers Squibb Company
Serum albumin binding molecules

Abstract:

The present invention relates to an antibody-like protein based on the tenth fibronectin type III domain (.sup.10Fn3) that binds to serum albumin. The invention further relates to fusion molecules comprising a serum albumin-binding .sup.10Fn3 joined to a heterologous protein for use in diagnostic and therapeutic applications.